You are using an older browser version. Please use a supported version for the best MSN experience.

Merck nears $40 billion deal for Seagen, report says

Pharma giant Merck is in advanced talks to acquire biotech Seagen in a deal valued at roughly $40 billion, according to a Wall Street Journal report.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon